Global Drugs for Herpes Labialis (Oral Herpes) Market Size, Status and Forecast 2023

Report ID: 1234763 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Aciclovir
        1.2.3 Valacyclovir
        1.2.4 Famciclovir
        1.2.5 Docosanol
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 External Use
        1.3.3 Oral
        1.3.4 Injection
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2016-2027)
    2.2 Drugs for Herpes Labialis (Oral Herpes) Growth Trends by Regions
        2.2.1 Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Drugs for Herpes Labialis (Oral Herpes) Historic Market Share by Regions (2016-2021)
        2.2.3 Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Regions (2022-2027)
    2.3 Drugs for Herpes Labialis (Oral Herpes) Industry Dynamic
        2.3.1 Drugs for Herpes Labialis (Oral Herpes) Market Trends
        2.3.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers
        2.3.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges
        2.3.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue
        3.1.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2016-2021)
        3.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2016-2021)
    3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Drugs for Herpes Labialis (Oral Herpes) Revenue
    3.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio
        3.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2020
    3.5 Drugs for Herpes Labialis (Oral Herpes) Key Players Head office and Area Served
    3.6 Key Players Drugs for Herpes Labialis (Oral Herpes) Product Solution and Service
    3.7 Date of Enter into Drugs for Herpes Labialis (Oral Herpes) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Type
    4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2016-2021)
    4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2022-2027)

5 Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Application
    5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2016-2021)
    5.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size (2016-2027)
    6.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        6.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021)
        6.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027)
        6.2.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2027)
    6.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        6.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021)
        6.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027)
        6.3.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2027)
    6.4 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        6.4.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021)
        6.4.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size (2016-2027)
    7.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        7.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021)
        7.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027)
        7.2.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2027)
    7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        7.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021)
        7.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027)
        7.3.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2027)
    7.4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        7.4.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021)
        7.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size (2016-2027)
    8.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        8.2.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        8.3.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region
        8.4.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size (2016-2027)
    9.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        9.2.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021)
        9.2.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027)
        9.2.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2027)
    9.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        9.3.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021)
        9.3.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027)
        9.3.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2027)
    9.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        9.4.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021)
        9.4.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size (2016-2027)
    10.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        10.2.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        10.3.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        10.4.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 GSK Business Overview
        11.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.1.5 GSK Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Teva
        11.3.1 Teva Company Details
        11.3.2 Teva Business Overview
        11.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.3.5 Teva Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Mylan Business Overview
        11.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.4.5 Mylan Recent Development
    11.5 Cadila
        11.5.1 Cadila Company Details
        11.5.2 Cadila Business Overview
        11.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.5.5 Cadila Recent Development
    11.6 Apotex
        11.6.1 Apotex Company Details
        11.6.2 Apotex Business Overview
        11.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.6.5 Apotex Recent Development
    11.7 Daewoong Pharmaceutical
        11.7.1 Daewoong Pharmaceutical Company Details
        11.7.2 Daewoong Pharmaceutical Business Overview
        11.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.7.5 Daewoong Pharmaceutical Recent Development
    11.8 Livzon
        11.8.1 Livzon Company Details
        11.8.2 Livzon Business Overview
        11.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.8.5 Livzon Recent Development
    11.9 Luoxin
        11.9.1 Luoxin Company Details
        11.9.2 Luoxin Business Overview
        11.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.9.5 Luoxin Recent Development
    11.10 Med shine
        11.10.1 Med shine Company Details
        11.10.2 Med shine Business Overview
        11.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.10.5 Med shine Recent Development
    11.11 Bayer (Campho Phenique)
        11.11.1 Bayer (Campho Phenique) Company Details
        11.11.2 Bayer (Campho Phenique) Business Overview
        11.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.11.5 Bayer (Campho Phenique) Recent Development
    11.12 Blistex
        11.12.1 Blistex Company Details
        11.12.2 Blistex Business Overview
        11.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.12.5 Blistex Recent Development
    11.13 Kelun
        11.13.1 Kelun Company Details
        11.13.2 Kelun Business Overview
        11.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.13.5 Kelun Recent Development
    11.14 Hikma
        11.14.1 Hikma Company Details
        11.14.2 Hikma Business Overview
        11.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.14.5 Hikma Recent Development
    11.15 Haiwang
        11.15.1 Haiwang Company Details
        11.15.2 Haiwang Business Overview
        11.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.15.5 Haiwang Recent Development
    11.16 Carmex
        11.16.1 Carmex Company Details
        11.16.2 Carmex Business Overview
        11.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.16.5 Carmex Recent Development
    11.17 Cipher
        11.17.1 Cipher Company Details
        11.17.2 Cipher Business Overview
        11.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
        11.17.5 Cipher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Aciclovir
    Table 3. Key Players of Valacyclovir
    Table 4. Key Players of Famciclovir
    Table 5. Key Players of Docosanol
    Table 6. Key Players of Other
    Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Regions (2016-2021)
    Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Regions (2022-2027)
    Table 13. Drugs for Herpes Labialis (Oral Herpes) Market Trends
    Table 14. Drugs for Herpes Labialis (Oral Herpes) Market Drivers
    Table 15. Drugs for Herpes Labialis (Oral Herpes) Market Challenges
    Table 16. Drugs for Herpes Labialis (Oral Herpes) Market Restraints
    Table 17. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players (2016-2021)
    Table 19. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2020)
    Table 20. Ranking of Global Top Drugs for Herpes Labialis (Oral Herpes) Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Drugs for Herpes Labialis (Oral Herpes) Product Solution and Service
    Table 24. Date of Enter into Drugs for Herpes Labialis (Oral Herpes) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2016-2021)
    Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2016-2021)
    Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. GSK Company Details
    Table 65. GSK Business Overview
    Table 66. GSK Drugs for Herpes Labialis (Oral Herpes) Product
    Table 67. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 68. GSK Recent Development
    Table 69. Novartis Company Details
    Table 70. Novartis Business Overview
    Table 71. Novartis Drugs for Herpes Labialis (Oral Herpes) Product
    Table 72. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 73. Novartis Recent Development
    Table 74. Teva Company Details
    Table 75. Teva Business Overview
    Table 76. Teva Drugs for Herpes Labialis (Oral Herpes) Product
    Table 77. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 78. Teva Recent Development
    Table 79. Mylan Company Details
    Table 80. Mylan Business Overview
    Table 81. Mylan Drugs for Herpes Labialis (Oral Herpes) Product
    Table 82. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 83. Mylan Recent Development
    Table 84. Cadila Company Details
    Table 85. Cadila Business Overview
    Table 86. Cadila Drugs for Herpes Labialis (Oral Herpes) Product
    Table 87. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 88. Cadila Recent Development
    Table 89. Apotex Company Details
    Table 90. Apotex Business Overview
    Table 91. Apotex Drugs for Herpes Labialis (Oral Herpes) Product
    Table 92. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 93. Apotex Recent Development
    Table 94. Daewoong Pharmaceutical Company Details
    Table 95. Daewoong Pharmaceutical Business Overview
    Table 96. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
    Table 97. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 98. Daewoong Pharmaceutical Recent Development
    Table 99. Livzon Company Details
    Table 100. Livzon Business Overview
    Table 101. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 102. Livzon Recent Development
    Table 103. Luoxin Company Details
    Table 104. Luoxin Business Overview
    Table 105. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
    Table 106. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 107. Luoxin Recent Development
    Table 108. Med shine Company Details
    Table 109. Med shine Business Overview
    Table 110. Med shine Drugs for Herpes Labialis (Oral Herpes) Product
    Table 111. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 112. Med shine Recent Development
    Table 113. Bayer (Campho Phenique) Company Details
    Table 114. Bayer (Campho Phenique) Business Overview
    Table 115. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product
    Table 116. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 117. Bayer (Campho Phenique) Recent Development
    Table 118. Blistex Company Details
    Table 119. Blistex Business Overview
    Table 120. Blistex Drugs for Herpes Labialis (Oral Herpes) Product
    Table 121. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 122. Blistex Recent Development
    Table 123. Kelun Company Details
    Table 124. Kelun Business Overview
    Table 125. Kelun Drugs for Herpes Labialis (Oral Herpes) Product
    Table 126. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 127. Kelun Recent Development
    Table 128. Hikma Company Details
    Table 129. Hikma Business Overview
    Table 130. Hikma Drugs for Herpes Labialis (Oral Herpes) Product
    Table 131. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 132. Hikma Recent Development
    Table 133. Haiwang Company Details
    Table 134. Haiwang Business Overview
    Table 135. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product
    Table 136. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 137. Haiwang Recent Development
    Table 138. Carmex Company Details
    Table 139. Carmex Business Overview
    Table 140. Carmex Drugs for Herpes Labialis (Oral Herpes) Product
    Table 141. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 142. Carmex Recent Development
    Table 143. Cipher Company Details
    Table 144. Cipher Business Overview
    Table 145. Cipher Drugs for Herpes Labialis (Oral Herpes) Product
    Table 146. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021) & (US$ Million)
    Table 147. Cipher Recent Development
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2020 VS 2027
    Figure 2. Aciclovir Features
    Figure 3. Valacyclovir Features
    Figure 4. Famciclovir Features
    Figure 5. Docosanol Features
    Figure 6. Other Features
    Figure 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2020 VS 2027
    Figure 8. External Use Case Studies
    Figure 9. Oral Case Studies
    Figure 10. Injection Case Studies
    Figure 11. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered
    Figure 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Regions: 2020 VS 2027
    Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Regions (2022-2027)
    Figure 16. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2020
    Figure 17. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2020
    Figure 19. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2016-2021)
    Figure 20. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2022-2027)
    Figure 21. North America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2016-2027)
    Figure 23. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2027)
    Figure 24. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2016-2027)
    Figure 25. United States Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2016-2027)
    Figure 29. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2027)
    Figure 30. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2016-2027)
    Figure 31. Germany Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2016-2027)
    Figure 41. China Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2016-2027)
    Figure 49. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2027)
    Figure 50. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2016-2027)
    Figure 51. Mexico Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2016-2027)
    Figure 57. Turkey Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 61. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 62. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 63. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 64. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 65. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 66. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 67. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 68. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 69. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 70. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 71. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 72. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 73. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 74. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 75. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 76. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher
Frequently Asked Questions
Drugs for Herpes Labialis (Oral Herpes) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drugs for Herpes Labialis (Oral Herpes) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drugs for Herpes Labialis (Oral Herpes) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Same-day Delivery

Same-day Delivery market is segmented by company, region (country), by Type, and by Application.  ... Read More

LED Module

LED Module market is segmented by company, region (country), by Type, and by Application. Players ... Read More